Granules India has received the Golden Peacock Award for Sustainability. This award was presented at the Institute of Directors’ Annual Global Convention on Corporate Governance & Sustainability being held in London, UK, and underscores Granules' dedication to sustainable practices within the pharmaceutical industry.
This recognition follows a highly competitive selection process with 499 applicants and a rigorous three-tier assessment, establishing Granules as a leader in sustainable practices in India. Granules India is especially honoured to be acknowledged by an esteemed jury, comprising former Chief Justices of India, the Vice-Chair of the GHG Protocol, and other prominent leaders in governance, law, and sustainability.
Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: